NR4A1 and breast carcinoma: Chu et al. [64] pioneered the use of ST to uncover significant differences in gene expression profiles between younger and older patients with hormone receptor-positive (HR-positive) breast cancer, highlighting the critical role of age in breast cancer biology and treatment.